Latest filing published 13 Oct 2026 for Retension Pharmaceuticals, Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Donald Olds: trading record in brief
Donald Olds has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Grace Therapeutics, Inc. and Retension Pharmaceuticals, Inc. Over a trading history stretching from 31 August 2023 to 13 October 2026, the count stands at 2 filings.
The open-market record is one-sided, with 1 purchase worth €720 and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
Most recently, on 13 October 2026, the filings show a transaction in Retension Pharmaceuticals, Inc. The most recent open-market purchase was published on 5 September 2023, 1,161 days ago. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Donald Olds
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,637 sharesCommon StockSEC:0001213900-26-109158:0
- 381 shares@ US$2.05100.0% of flowCommon SharesSEC:0001062993-23-017516:0Canonical exit: 29 Nov 2023 (T+90)
2 of 2 declarations
